Why Do Influenza Virus Subtypes Die Out? A Hypothesis

por Palese, Peter, Wang, Taia T.
Publicado 2011

The Role of Fc Gamma Receptors in Broad Protection against Influenza Viruses

por Thulin, Natalie K., Wang, Taia T.
Publicado 2018

Illuminating the Fc dependence of SARS-CoV-2 neutralization

por González, Joseph C., Wang, Taia T.
Publicado 2021

An aberrant inflammatory response in severe COVID-19

por Merad, Miriam, Subramanian, Aruna, Wang, Taia T.
Publicado 2021

Heterogeneity in IgG‐CD16 signaling in infectious disease outcomes

por Gonzalez, Joseph C., Chakraborty, Saborni, Thulin, Natalie K., Wang, Taia T.
Publicado 2022

SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

por Chakraborty, Saborni, Mallajosyula, Vamsee, Tato, Cristina M., Tan, Gene S., Wang, Taia T.
Publicado 2021

Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins

por Wang, Taia T., Tan, Gene S., Hai, Rong, Pica, Natalie, Petersen, Erin, Moran, Thomas M., Palese, Peter
Publicado 2010

Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain

por Steel, John, Lowen, Anice C., Wang, Taia T., Yondola, Mark, Gao, Qinshan, Haye, Kester, García-Sastre, Adolfo, Palese, Peter
Publicado 2010

Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants

por Thulin, Natalie K., Brewer, R. Camille, Sherwood, Robert, Bournazos, Stylianos, Edwards, KarlieG., Ramadoss, Nitya S., Taubenberger, Jeffery K., Memoli, Matthew, Gentles, Andrew J., Jagannathan, Prasanna, Zhang, Sheng, Libraty, Daniel H., Wang, Taia T.
Publicado 2020

Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding

por Byrnes, James R., Zhou, Xin X., Lui, Irene, Elledge, Susanna K., Glasgow, Jeff E., Lim, Shion A., Loudermilk, Rita P., Chiu, Charles Y., Wang, Taia T., Wilson, Michael R., Leung, Kevin K., Wells, James A.
Publicado 2020

Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19

por Pickering, Chad, Zhou, Bo, Xu, Gege, Rice, Rachel, Ramachandran, Prasanna, Huang, Hector, Pham, Tho D., Schapiro, Jeffrey M., Cong, Xin, Chakraborty, Saborni, Edwards, Karlie, Reddy, Srinivasa T., Guirgis, Faheem, Wang, Taia T., Serie, Daniel, Lindpaintner, Klaus
Publicado 2022

B cell clonal expansion and convergent antibody responses to SARS-CoV-2

por Nielsen, Sandra C. A., Yang, Fan, Hoh, Ramona A., Jackson, Katherine J. L., Roeltgen, Katharina, Lee, Ji-Yeun, Rustagi, Arjun, Rogers, Angela J., Powell, Abigail E., Kim, Peter S., Wang, Taia T., Pinsky, Benjamin, Blish, Catherine A., Boyd, Scott D.
Publicado 2020

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

por Blanco-Melo, Daniel, Nilsson-Payant, Benjamin E., Liu, Wen-Chun, Uhl, Skyler, Hoagland, Daisy, Møller, Rasmus, Jordan, Tristan X., Oishi, Kohei, Panis, Maryline, Sachs, David, Wang, Taia T., Schwartz, Robert E., Lim, Jean K., Albrecht, Randy A., tenOever, Benjamin R.
Publicado 2020

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

por Gorog, Diana A., Storey, Robert F., Gurbel, Paul A., Tantry, Udaya S., Berger, Jeffrey S., Chan, Mark Y., Duerschmied, Daniel, Smyth, Susan S., Parker, William A. E., Ajjan, Ramzi A., Vilahur, Gemma, Badimon, Lina, Berg, Jurrien M. ten, Cate, Hugo ten, Peyvandi, Flora, Wang, Taia T., Becker, Richard C.
Publicado 2022

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

por Elledge, Susanna K., Zhou, Xin X., Byrnes, James R., Martinko, Alexander J., Lui, Irene, Pance, Katarina, Lim, Shion A., Glasgow, Jeff E., Glasgow, Anum A., Turcios, Keirstinne, Iyer, Nikita, Torres, Leonel, Peluso, Michael J., Henrich, Timothy J., Wang, Taia T., Tato, Cristina M., Leung, Kevin K., Greenhouse, Bryan, Wells, James A.
Publicado 2020

Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19

por Hu, Zicheng, van der Ploeg, Kattria, Chakraborty, Saborni, Arunachalam, Prabhu, Mori, Diego, Jacobson, Karen, Bonilla, Hector, Parsonnet, Julie, Andrews, Jason, Hedlin, Haley, de la Parte, Lauren, Dantzler, Kathleen, Ty, Maureen, Tan, Gene, Blish, Catherine, Takahashi, Saki, Rodriguez-Barraquer, Isabel, Greenhouse, Bryan, Butte, Atul, Singh, Upinder, Pulendran, Bali, Wang, Taia, Jagannathan, Prasanna
Publicado 2022

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses

por Sievers, Benjamin L., Chakraborty, Saborni, Xue, Yong, Gelbart, Terri, Gonzalez, Joseph C., Cassidy, Arianna G., Golan, Yarden, Prahl, Mary, Gaw, Stephanie L., Arunachalam, Prabhu S., Blish, Catherine A., Boyd, Scott D., Davis, Mark M., Jagannathan, Prasanna, Nadeau, Kari C., Pulendran, Bali, Singh, Upinder, Scheuermann, Richard H., Frieman, Matthew B., Vashee, Sanjay, Wang, Taia T., Tan, Gene S.
Publicado 2022

Human B cell clonal expansion and convergent antibody responses to SARS CoV-2

por Nielsen, Sandra C. A., Yang, Fan, Jackson, Katherine J. L., Hoh, Ramona A., Röltgen, Katharina, Stevens, Bryan, Lee, Ji-Yeun, Rustagi, Arjun, Rogers, Angela J., Powell, Abigail E., Najeeb, Javaria, Otrelo-Cardoso, Ana R., Yost, Kathryn E., Daniel, Bence, Chang, Howard Y., Satpathy, Ansuman T., Jardetzky, Theodore S., Kim, Peter S., Wang, Taia T., Pinsky, Benjamin A., Blish, Catherine A., Boyd, Scott D.
Publicado 2020

Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial

por Jagannathan, Prasanna, Andrews, Jason R., Bonilla, Hector, Hedlin, Haley, Jacobson, Karen B., Balasubramanian, Vidhya, Purington, Natasha, Kamble, Savita, de Vries, Christiaan R., Quintero, Orlando, Feng, Kent, Ley, Catherine, Winslow, Dean, Newberry, Jennifer, Edwards, Karlie, Hislop, Colin, Choong, Ingrid, Maldonado, Yvonne, Glenn, Jeffrey, Bhatt, Ami, Blish, Catherine, Wang, Taia, Khosla, Chaitan, Pinsky, Benjamin A., Desai, Manisha, Parsonnet, Julie, Singh, Upinder
Publicado 2021

TNF-α(+) CD4(+) T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies

por van der Ploeg, Kattria, Kirosingh, Adam S., Mori, Diego A.M., Chakraborty, Saborni, Hu, Zicheng, Sievers, Benjamin L., Jacobson, Karen B., Bonilla, Hector, Parsonnet, Julie, Andrews, Jason R., Press, Kathleen D., Ty, Maureen C., Ruiz-Betancourt, Daniel R., de la Parte, Lauren, Tan, Gene S., Blish, Catherine A., Takahashi, Saki, Rodriguez-Barraquer, Isabel, Greenhouse, Bryan, Singh, Upinder, Wang, Taia T., Jagannathan, Prasanna
Publicado 2022